N-(2-Diethylamino)Ethyl)-5-Formyl-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide

Batch records from multi-kilogram GMP campaigns indicate that residual moisture in the pyrrole-carboxamide starting material routinely exceeds 0.15% by Karl Fischer titration after ambient storage, necessitating azeotropic drying with toluene prior to condensation reactions. Failure to reduce water content below 0.05% results in incomplete Schiff base formation with primary amines, generating isolable hemiaminal intermediates that revert to starting aldehydes during silica gel chromatography. The aldehyde group at position 5 of the pyrrole ring exhibits attenuated electrophilicity relative to benzaldehyde derivatives, attributable to electron donation from the 2,4-dimethyl substituents, and quantitative conversion with anilines typically requires 1.2–1.5 molar equivalents of amine in refluxing ethanol with 0.5% glacial acetic acid as catalyst over 16–24 hours.

When Photodynamic Therapy Demands Non-Porphyrin Photosensitizers

The diethylaminoethyl side chain confers water-solubility at physiological pH that is absent in protoporphyrin IX precursors, enabling formulation of injectable photosensitizers without Cremophor EL or liposomal encapsulation. In the synthesis of chlorin-e6 conjugates, the formyl group at position 5 is condensed with hydrazine-functionalized targeting peptides under mildly acidic conditions (pH 4.5–5.0, sodium acetate buffer) to yield acid-labile hydrazone linkages that cleave selectively within the lysosomal compartment of tumor cells. Manufacturing campaigns under ICH Q7 Section 8.4 (reprocessing) have demonstrated that the hydrazone conjugation step tolerates dissolved oxygen levels up to 5 ppm, but exposure to ambient light during work-up must be strictly controlled—photodegradation products detectable by HPLC at 254 nm exceed 0.5 area% after 30 minutes of fluorescent room lighting. The active pharmaceutical ingredient is isolated as the hydrochloride salt (stoichiometric addition of 1.05 equivalents of HCl in isopropanol) to ensure aqueous solubility exceeding 50 mg/mL for reconstitution. Terminal sterilization via 0.22 µm PVDF membrane filtration is validated per ISO 13408-1:2023, though filter compatibility studies reveal adsorption losses of 2–3% on mixed cellulose ester membranes, mandating PVDF or PES materials exclusively. The final lyophilized cake contains the conjugate at 89–92 wt% with mannitol as bulking agent and residual ethanol below ICH Q3C Guideline Option 2 limits of 5,000 ppm. Analytical release specifications include purity by HPLC (≥98.0%), bacterial endotoxins (<0.5 EU/mg per USP <85>), and residual hydrazine (<1 ppm by derivatization GC-MS per Ph.Eur. 2.5.37).

Published investigations into the addition ratio reveal a narrow processing window: at 0.9 molar equivalents of peptide-hydrazine relative to the formyl pyrrole intermediate, unreacted aldehyde persists through chromatography and forms adducts with lysine residues on the targeting peptide during lyophilization; at 1.3 equivalents, excess hydrazine-functionalized peptide competes for binding sites in cellular uptake assays, reducing photocytotoxicity by 15–20%. Production-scale batch records from a 50 L jacketed glass reactor (Buchi AG, Uster) specify incremental addition of the peptide solution over 90 minutes at 22 ± 2°C to maintain the desired stoichiometry while avoiding localized reagent excess. Post-conjugation, the reaction is quenched with 2.0 equivalents of sodium borohydride relative to unreacted aldehyde (determined by in-process TLC, silica gel 60 F₂₅₄, ethyl acetate:methanol 4:1 v/v) and stirred for 2 hours before pH adjustment to 7.0 and purification by preparative reverse-phase HPLC (C18, 10 µm, 250 × 50 mm column, acetonitrile/water/0.1% TFA gradient).

Boron-dipyrromethene derivatives prepared from this formyl-pyrrole scaffold via condensation with 2,4-dimethylpyrrole under TFA catalysis (BODIPY core formation) exhibit molar extinction coefficients exceeding 80,000 M⁻¹cm⁻¹ at 502 nm in dichloromethane, with fluorescence quantum yields of 0.72–0.85 when the diethylaminoethyl substituent is quaternized to suppress photoinduced electron transfer. The quaternization step employs methyl iodide (3.0 equivalents) in acetonitrile at 40°C for 6 hours, and residual methyl iodide is scavenged with polymer-bound triphenylphosphine (1.5 mmol/g loading, 2.0 equivalents) before filtration. Terminal product types include sulfonated BODIPY dyes for confocal microscopy (Ex/Em 495/508 nm), amine-reactive NHS ester derivatives for antibody labeling, and alkyne-functionalized variants for copper-catalyzed click conjugation to azide-modified oligonucleotides.

Process validation batches at pilot scale ( 10–20 kg output of the formyl intermediate) have identified a critical dependency on the quality of the Vilsmeier-Haack reagent prepared from DMF and phosphorus oxychloride. Exothermic rise during POCl₃ addition to DMF must not exceed 10°C/min, and the resulting iminium salt solution must be aged for exactly 45 minutes at 0–5°C before pyrrole addition. Shorter aging leads to unreacted POCl₃ that chlorinates the pyrrole 4-position; extended aging precipitates an intractable iminium salt complex that reduces formylation yield to < 40%. The workup quench into ice water generates a transient exotherm ( +18°C over 20 seconds in a 100 L vessel) and the pH during neutralization with 50% aqueous sodium hydroxide must be maintained below 8.0 to prevent Aldol self-condensation of the product. The crude product is extracted into dichloromethane (3 × 30 L), dried over anhydrous sodium sulfate, and crystallized from ethyl acetate/heptane (1:3 v/v) to yield pale yellow needles with melting point 148–150°C (literature 147–149°C) and GC purity 99.2%.

Beyond simple Europium chelates: time-resolved fluorescence in clinical diagnostics

The diethylaminoethyl arm functions as a ligand-directing group that coordinates to lanthanide ions in pre-organized geometries distinct from those adopted by simple β-diketonate ligands. When the formyl group is converted to a carboxaldehyde-hydrazone with diethylenetriaminepentaacetic acid (DTPA) monoanhydride, the resulting heptadentate chelator binds Eu³⁺ with a stability constant (log K) of 18.2 ± 0.3 in 0.1 M Tris buffer at pH 7.4, as measured by competition potentiometry against EDTA. This stability constant is operationally sufficient for DELFIA®-type dissociation-enhanced assays, where the europium label is released into an acidic micellar solution ( 0.1 M acetate buffer pH 3.2 with 0.5% Triton X-100, 15 µM thenoyltrifluoroacetone, 50 µM tri-n-octylphosphine oxide) prior to time-resolved measurement. The incorporation ratio in the final lyophilized tracer is typically 8–12 europium atoms per IgG molecule when derivatized through the carboxamide nitrogen rather than through the diethylaminoethyl group, because modification at the tertiary amine reduces Eu³⁺ binding affinity by 2–3 orders of magnitude due to steric crowding of the first coordination sphere.

Conjugation of this chelator to monoclonal antibodies proceeds through the 3-carboxamide position after hydrazinolysis of the formyl-DTPA adduct with 80% hydrazine hydrate in methanol at reflux for 4 hours. The resulting hydrazide is diazotized at 0°C with sodium nitrite in 0.5 M HCl to form the acyl azide, which is added dropwise to a solution of the antibody (5 mg/mL) in 0.1 M sodium bicarbonate pH 8.3 at 4°C. The molar labeling ratio is controlled by adjusting the acyl azide:antibody stoichiometry between 20:1 and 40:1; ratios below 15:1 produce incomplete derivatization (< 4 Eu/IgG) while ratios above 60:1 induce precipitation of the conjugate due to hydrophobic chelator clustering. Post-conjugation purification by size-exclusion chromatography (Superdex 200 Increase 10/300 GL, PBS pH 7.4) removes unconjugated chelator and aggregated species, with the monomeric IgG peak collected between 12.5–14.8 mL elution volume. Storage stability studies at 4°C in PBS with 0.05% sodium azide demonstrate immunoreactivity retention (> 90%) and Eu³⁺ dissociation (< 5%) over 18 months when the conjugate concentration is maintained above 0.1 mg/mL.

Diagnostic manufacturers implementing this technology in automated immunoassay platforms (e.g., PerkinElmer AutoDELFIA®, Roche cobas® e 801) must validate that the diethylaminoethyl functionality does not cross-react with heterophilic antibody interference in patient sera. Blocking studies with aggregated murine IgG (500 µg/mL) and proprietary heterophilic blocking reagent HBR-1 (Scantibodies Laboratory, 100 µg/mL) reduce false-positive signals from the chelator moiety to less than 0.05% of total signal. The terminal diagnostic kits are registered as Class II medical devices under FDA 21 CFR 866 for clinical chemistry and toxicology analytes, with the time-resolved fluorescence readout at 615 nm (excitation 340 nm, delay 400 µs, window 400 µs) providing a lower limit of detection of 0.1 pmol/L for thyroid-stimulating hormone in serum-based calibrators traceable to WHO IRP 80/558.

Temperature-dependent Eu³⁺ emission lifetime measurements show a monoexponential decay of 620 ± 25 µs at 25°C in the micellar enhancement solution, decreasing to 485 ± 30 µs at 37°C due to enhanced non-radiative deactivation through O-H oscillator coupling with water molecules in the second coordination sphere. Instrument calibration protocols require lifetime validation with a europium standard (PerkinElmer, cat. no. 1244-301) at the start of each analytical run, and the coefficient of variation on lifetime measurements across 96-well plates must remain below 2.5% for assay acceptance.

Where UV-Vis absorption beyond 600 nm is a photothermal requirement

Fused-ring expansion of the 5-formyl-2,4-dimethylpyrrole core with malononitrile under Knoevenagel conditions (piperidine, ethanol, reflux 3 hours) installs a dicyanovinyl acceptor that extends the π-conjugation pathway and shifts the lowest-energy absorption band from 320 nm in the parent aldehyde to 580–620 nm in the push-pull chromophore. This bathochromic shift is tunable: substitution of the diethylamino donor with dibutylamino raises the λmax to 635 nm, and inclusion of a thiophene spacer between the pyrrole and dicyanovinyl groups further red-shifts to 680 nm while increasing the molar extinction coefficient to 95,000 M⁻¹cm⁻¹ in chloroform. These near-infrared absorbing chromophores are evaluated as photothermal agents for in vivo tumor ablation under irradiation with a 660 nm diode laser at power densities of 0.5–1.0 W/cm², where photothermal conversion efficiencies—calculated from the linear time constant method using a thermal imaging camera (FLIR A655sc, 50 mK sensitivity)—reach 48–52% for the thiophene-extended derivative, outperforming indocyanine green ( 18%) under identical irradiation conditions.

Formulation of these chromophores for intravenous administration requires encapsulation in PEGylated polylactic-co-glycolic acid nanoparticles prepared by nanoprecipitation. The pyrrole-chromophore is dissolved with PLGA ( 50:50 lactide:glycolide, Mw 30–60 kDa, Evonik Resomer® RG 504 H) in acetone at a drug:polymer ratio of 1:10 w/w and added dropwise to 0.5% aqueous polyvinyl alcohol under sonication (probe sonicator, 40% amplitude, 2 minutes). Dynamic light scattering (Malvern Zetasizer Nano ZS) of the resulting dispersion indicates a hydrodynamic diameter of 120 ± 15 nm with a polydispersity index of 0.12. The encapsulation efficiency determined by UV-Vis spectrophotometry after lyophilization and redissolution in acetonitrile is 78 ± 5%, with the balance lost to the aqueous phase during solvent evaporation. Residual acetone is removed by rotary evaporation at 30°C under reduced pressure (200 mbar), and the nanoparticle suspension is sterile-filtered through a 0.45 µm PVDF membrane before lyophilization with 5% trehalose as cryoprotectant. The product specification for photothermal performance mandates a temperature increase of ≥30°C in a phantom tissue model ( 1% agarose, 100 µL well volume, 100 µg/mL nanoparticle concentration) within 10 minutes of laser irradiation at 1 W/cm².

Extrusion compounding of these chromophores into polyurethane catheter materials for antimicrobial photodynamic applications has been explored at lab scale using a Thermo Scientific HAAKE MiniCTW conical twin-screw micro-compounder with a recirculation channel. Processing at 180°C barrel temperature and 100 rpm screw speed with a 0.5 wt% chromophore loading in Tecoflex® EG-80A polyurethane achieves uniform dispersion without observable thermal degradation of the dicyanovinyl chromophore when residence time is limited to 3 minutes. The extruded strand is pelletized and compression-molded into 0.5 mm films at 185°C for 2 minutes under 10 MPa. UV-Vis spectroscopy of the molded films confirms retention of the NIR absorption band with < 5% hypsochromic shift, and singlet oxygen generation measured with 1,3-diphenylisobenzofuran as chemical trap under 660 nm LED illumination exceeds 0.15 µmol/min per gram of film. The regulatory pathway for such drug-device combination products falls under FDA 21 CFR Part 4 with the photothermal agent regulated as a drug constituent and the catheter substrate as a device constituent.

Long-term photostability under continuous irradiation presents the primary technical barrier for commercial translation. Accelerated aging studies under 660 nm laser illumination at 1.5 W/cm² ( 1.5× clinical intensity) reveal a first-order photobleaching rate constant of 2.8 × 10⁻³ min⁻¹ for the thiophene-extended derivative in PLGA nanoparticles, corresponding to a half-life of 4.1 hours. This photobleaching is accompanied by a 15 nm hypsochromic shift in the absorption maximum, and HPLC-MS analysis of the photodegradation mixture identifies a dioxetane intermediate formed by cycloaddition of singlet oxygen to the dicyanovinyl double bond. Addition of the singlet oxygen quencher 1,4-diazabicyclo[2.2.2]octane (DABCO, 10 mM) to the nanoparticle matrix extends the photobleaching half-life to 8.7 hours, but DABCO leaching into aqueous media at 37°C ( 22% release at 24 hours by ion chromatography) limits the practical benefit for in vivo applications.

Thermogravimetric analysis coupled with differential scanning calorimetry of the pure chromophore reveals a sharp melting endotherm at 212°C (onset 208°C, enthalpy 112 J/g) followed immediately by exothermic decomposition with a peak at 218°C, consistent with the thermal lability of the dicyanovinyl group. This narrow processing window of 6°C between melt and decomposition restricts melt-processing to short residence times and mandates nitrogen purging (O₂ < 50 ppm) to suppress oxidative degradation. Injection molding trials with the chromophore dispersed in cyclic olefin copolymer (TOPAS® 6013S-04) at 0.2 wt% loading were conducted on an Arburg Allrounder 370 A 600-170 with a 25 mm screw, barrel temperature profile 190/200/210/215°C from feed to nozzle, and injection speed of 40 cm³/s. Molded plaques (60 × 60 × 2 mm) exhibited visible absorption at 672 nm with an optical density of 0.8 ± 0.05 across the surface, indicating uniform dispersion and minimal thermal degradation when the total residence time in the plastication unit was kept below 90 seconds.

Chromogenic signaling of volatile amine release in intelligent packaging

Reactive extrusion of the formyl-pyrrole intermediate with aliphatic diamines directly within low-density polyethylene produces a chromogenic masterbatch that undergoes a visible yellow-to-deep-red color transition upon exposure to headspace ammonia or dimethylamine. The chemistry exploits a solid-state imine exchange: the formyl group is pre-reacted with octylamine ( 1.0 equivalent, ethanol, 60°C, 2 hours) to form a yellow Schiff base that is then melt-blended into LDPE (MFI 2.0 g/10 min at 190°C/2.16 kg, ISO 1133-1:2022) at 2.0 wt% loading using a co-rotating twin-screw extruder (Coperion ZSK 26 Mc18, L/D 40, 26 mm screw diameter) at 160°C barrel temperature and 300 rpm screw speed. When the extruded film ( 80 ± 10 µm thickness, blown film die 50 mm diameter, blow-up ratio 2.5:1) is exposed to headspace ammonia concentrations above 5 ppm, the octylimine undergoes transimination with ammonia, releasing octylamine into the polymer matrix and generating the free imine of ammonia, which absorbs at 485 nm due to reduced steric crowding around the chromophore. The color change (ΔE > 15 CIELAB units at 25 ppm ammonia) is detectable by smartphone-based RGB imaging (ColorGrab app, L* a* b* calibration with X-Rite ColorChecker Passport) with a limit of detection of 2 ppm ammonia, and the response is irreversible under ambient conditions, making it suitable for cumulative exposure monitoring rather than real-time sensing.

The masterbatch formulation incorporates a dispersion aid (Licowax® OP, 0.3 phr) and an acid scavenger (calcium stearate, 0.1 phr) to prevent premature hydrolysis of the Schiff base during extrusion by residual moisture in the LDPE pellets. Pre-drying of the LDPE at 80°C for 4 hours in a desiccant dryer (dew point −40°C) is mandatory before compounding; skipping this step results in 30–40% reduction in chromophore intensity due to imine hydrolysis catalyzed by trace water at processing temperatures. The extruded pellets are let down at 10:1 (virgin LDPE:masterbatch) for blown film production, resulting in a final chromophore concentration of 0.2 wt% in the packaging film. Migration testing per EU Regulation 10/2011 on food contact materials (simulant D2, vegetable oil, 10 days at 40°C) shows non-detectable migration of the chromophore (< 0.01 mg/kg by HPLC-DAD, LOQ 0.01 mg/kg), and specific migration of octylamine is below the detection limit of 0.05 mg/kg (GC-MS headspace, LOQ 0.05 mg/kg).

Industrial-scale blown film trials on a Reifenhäuser Evolution II line (70 mm extruder, L/D 30, throughput 180 kg/hr, melt temperature 175°C) with the 0.2 wt% chromophore loading produced film with a tensile strength at break of 22 MPa (MD) and 18 MPa (TD) per ASTM D882-18, compared to 23 MPa (MD) and 19 MPa (TD) for the unfilled LDPE control, indicating negligible deterioration of mechanical properties. The oxygen transmission rate measured at 23°C, 0% RH per ASTM D3985-17 was 3,800 cm³/m²·day·atm for both chromophore-containing and control films, confirming that the low chromophore loading does not alter barrier properties. Colorimetric response kinetics follow a pseudo-first-order rate model with an observed rate constant of 0.042 min⁻¹ at 25 ppm ammonia and 23°C, and the response reaches 90% of the final ΔE value within 45 minutes of exposure.

The intelligent packaging concept has been validated for fresh fish spoilage monitoring in modified atmosphere packaging (MA-Pack, 40% CO₂/60% N₂) where total volatile basic nitrogen concentrations in the headspace correlate with established sensory rejection thresholds of 25–35 mg N/100 g muscle for white fish species. The diethylaminoethyl substituent does not interfere with the transimination chemistry, as the tertiary amine is protonated in the acidic environment of the carboxylic acid-functionalized LDPE (achieved by incorporating 5 wt% of an ethylene-acrylic acid copolymer, Nucrel® 960) and is thus unavailable for competing Schiff base formation. Published data for the long-term photostability of this specific chromophore in LDPE under retail display lighting (fluorescent, 1,000 lux, 12 hr/day cycle) is limited, but accelerated QUV testing (340 nm UVA lamps, 0.77 W/m², 50°C, ASTM G154-23) shows < 10% decrease in ΔE response over 200 hours of exposure, corresponding to approximately 3 months of simulated retail conditions.

The regulatory pathway for commercial deployment under EU 1935/2004 (Framework Regulation on food contact materials) requires a Declaration of Compliance supported by migration test data per the appropriate simulant directive, and the intelligent function—classified as an active and intelligent material under Article 3—necessitates a specific authorization for the chromogenic additive that is currently under EFSA evaluation as a new food contact substance. Manufacturers supplying the packaged seafood market should verify that the specific diamine transimination product formed upon fish spoilage is listed on the Union List of authorized substances or is covered by a functional barrier assessment demonstrating no migration above 0.01 mg/kg.